Coloplast A/S CLPBF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 33.23% | 85.81% | -218.21% | 45.94% | -29.21% |
| Total Depreciation and Amortization | 12.34% | 8.28% | 12.64% | 14.72% | -9.59% |
| Total Amortization of Deferred Charges | -37.03% | -- | -- | -- | 124.91% |
| Total Other Non-Cash Items | -56.15% | -117.46% | 402.41% | -27.21% | 361.66% |
| Change in Net Operating Assets | 258.37% | 63.70% | 48.42% | 15.40% | -8.88% |
| Cash from Operations | 12.70% | 7.27% | 119.35% | 21.34% | 17.57% |
| Capital Expenditure | 6.51% | 30.00% | -60.19% | -45.94% | 0.20% |
| Sale of Property, Plant, and Equipment | -1.66% | 304.67% | 676.97% | -45.48% | -91.14% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -164.97% | 3.08% | -173.85% | 10.18% | 52.98% |
| Cash from Investing | -3.59% | 28.70% | -119.89% | -237.85% | 4.03% |
| Total Debt Issued | -144.13% | -7,050.00% | 2.69% | 17.78% | 163.13% |
| Total Debt Repaid | 30.28% | 505.80% | -461.84% | -2.99% | -3,571.43% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -2.22% | -- | -15.50% | -- |
| Other Financing Activities | -5.90% | -- | -- | -- | -- |
| Cash from Financing | -49.06% | -45.17% | -73.40% | -1.69% | -2.74% |
| Foreign Exchange rate Adjustments | 109.83% | 139.60% | 275.79% | -121.82% | 24.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -236.10% | -8,426.54% | 63.62% | 64.52% | 337.30% |